132 related articles for article (PubMed ID: 28665158)
1. Dissolution and bioavailability enhancement of alpha-asarone by solid dispersions via oral administration.
Deng L; Wang Y; Gong T; Sun X; Zhang ZR
Drug Dev Ind Pharm; 2017 Nov; 43(11):1817-1826. PubMed ID: 28665158
[TBL] [Abstract][Full Text] [Related]
2. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
Thenmozhi K; Yoo YJ
Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
4. Poloxamer-based solid dispersions for oral delivery of docetaxel: Differential effects of F68 and P85 on oral docetaxel bioavailability.
Song CK; Yoon IS; Kim DD
Int J Pharm; 2016 Jun; 507(1-2):102-8. PubMed ID: 27154250
[TBL] [Abstract][Full Text] [Related]
5. Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol.
Vasconcelos T; Prezotti F; Araújo F; Lopes C; Loureiro A; Marques S; Sarmento B
Int J Pharm; 2021 Feb; 595():120245. PubMed ID: 33484925
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68.
Chen Y; Zhang GG; Neilly J; Marsh K; Mawhinney D; Sanzgiri YD
Int J Pharm; 2004 Nov; 286(1-2):69-80. PubMed ID: 15501003
[TBL] [Abstract][Full Text] [Related]
7. Improved solubility, dissolution, and oral bioavailability for atorvastatin-Pluronic® solid dispersions.
Shaker MA; Elbadawy HM; Shaker MA
Int J Pharm; 2020 Jan; 574():118891. PubMed ID: 31786357
[TBL] [Abstract][Full Text] [Related]
8. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
Chella N; Tadikonda R
Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
[TBL] [Abstract][Full Text] [Related]
10. Development and in vitro evaluation of solid dispersions as strategy to improve albendazole biopharmaceutical behavior.
Simonazzi A; Cid AG; Paredes AJ; Schofs L; Gonzo EE; Palma SD; Bermúdez JM
Ther Deliv; 2018 Sep; 9(9):623-638. PubMed ID: 30189808
[TBL] [Abstract][Full Text] [Related]
11. Dissolution and oral bioavailability enhancement of praziquantel by solid dispersions.
Liu Y; Wang T; Ding W; Dong C; Wang X; Chen J; Li Y
Drug Deliv Transl Res; 2018 Jun; 8(3):580-590. PubMed ID: 29450806
[TBL] [Abstract][Full Text] [Related]
12. Effect of binary and ternary solid dispersions on the in vitro dissolution and in-situ rabbit intestinal absorption of gliclazide.
El-Maghraby GM; Alomrani AH
Pak J Pharm Sci; 2011 Oct; 24(4):459-68. PubMed ID: 21959805
[TBL] [Abstract][Full Text] [Related]
13. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
14. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.
Eedara BB; Veerareddy PR; Jukanti R; Bandari S
Drug Dev Ind Pharm; 2014 Aug; 40(8):1030-43. PubMed ID: 23738504
[TBL] [Abstract][Full Text] [Related]
15. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers.
Xu WJ; Xie HJ; Cao QR; Shi LL; Cao Y; Zhu XY; Cui JH
Drug Deliv; 2016; 23(1):41-8. PubMed ID: 24735247
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of Oral Bioavailability of Curcumin by a Novel Solid Dispersion System.
Hu L; Shi Y; Li JH; Gao N; Ji J; Niu F; Chen Q; Yang X; Wang S
AAPS PharmSciTech; 2015 Dec; 16(6):1327-34. PubMed ID: 25804949
[TBL] [Abstract][Full Text] [Related]
17. Binary and ternary solid dispersions of an anticancer preclinical lead, IIIM-290: In vitro and in vivo studies.
Kumar V; Mintoo MJ; Mondhe DM; Bharate SB; Vishwakarma RA; Bharate SS
Int J Pharm; 2019 Oct; 570():118683. PubMed ID: 31513869
[TBL] [Abstract][Full Text] [Related]
18. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
Dhumal RS; Biradar SV; Aher S; Paradkar AR
J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
[TBL] [Abstract][Full Text] [Related]
19. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
20. Effect of semicrystalline polymers on self-emulsifying solid dispersions of nateglinide: in vitro and in vivo evaluation.
Swain RP; Subudhi BB
Drug Dev Ind Pharm; 2018 Jan; 44(1):56-65. PubMed ID: 28845687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
